Le Lézard
Classified in: Business
Subjects: NPT, CHI

Childhood Cancer Canada Opens the Market


TORONTO, Feb. 15, 2019 /CNW/ - Sandi Hancox, VP Fundraising, Childhood Cancer Canada (CCC), joined Shaun McIver, Chief Client Officer, TMX Group, to open the market in celebration of February 15 as International Childhood Cancer Awareness Day. CCC has a 30-year history of supporting families through their cancer journey. The foundation dedicates funds to life saving research while delivering outreach, education and community programs. CCC has launched the registration of their Survivor Scholarship program, which provides scholarships to childhood cancer survivors across Canada.

Childhood Cancer Canada Opens the Market (CNW Group/TMX Group Limited)

SOURCE TMX Group Limited


These press releases may also interest you

at 07:50
Alight, Inc. , a leading cloud-based provider of integrated digital human capital and business solutions, today reported results for the first quarter ended March 31, 2024. "It has been an exciting start to the year for Alight, with the announced...

at 07:45
IntelGenx Technologies Corp. (the "Company" or "IntelGenx") announces that, at the annual meeting of shareholders of the Company held on May 7, 2024 (the "Annual Meeting"), shareholders voted in favour of all items of business put forth by the...

at 07:35
Holley Performance Brands , a leader in automotive aftermarket performance solutions, today announced financial results for its first quarter ended March 31, 2024. First Quarter Highlights vs. Prior Year Period Net Sales decreased 7.9% to $158.6...

at 07:35
Payoneer Global Inc. ("Payoneer" or the "Company") , the financial technology company empowering the world's small and medium-sized businesses to transact, do business and grow globally, today reported financial results for its first quarter ended...

at 07:35
Griffon Corporation ("Griffon" or the "Company") today reported results for the fiscal 2024 second quarter ended March 31, 2024. Revenue for the second quarter totaled $672.9 million, a 5% decrease compared to $711.0 million in the prior year...

at 07:35
Crescita Therapeutics Inc. ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the first quarter ended March 31, 2024 ("Q1-2024"). All amounts...



News published on and distributed by: